VAC
Vincristine, Dactinomycin, Cyclophosphamide · Pediatric Soft Tissue Sarcoma Regimen
Indications & Uses
Standard therapy for Pediatric Rhabdomyosarcoma and Ewing Sarcoma family of tumors.
Contraindications
Severe hepatic dysfunction, severe bone marrow aplasia.
Side Effects & Warnings
Severe myelosuppression, veno-occlusive disease (dactinomycin), hemorrhagic cystitis, peripheral neuropathy.
Drug & Dietary Interactions
Extensive interactions; consult specific multi-agent administration and hydration protocols.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.